This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Medicago Inc.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Sonia Trépanier: Innovator in Influenza Vaccine Development
Introduction
Sonia Trépanier is a notable inventor based in St-Nicolas, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of influenza vaccines. Her innovative work focuses on synthesizing virus-like particles that can enhance vaccine efficacy.
Latest Patents
Sonia Trépanier holds a patent for "Influenza virus-like particles (VLPs) comprising hemagglutinin produced within a plant." This invention provides a method for synthesizing influenza VLPs within a plant or a portion of a plant. The process involves the expression of influenza hemagglutinin (HA) in plants, followed by purification through size exclusion chromatography. The invention also encompasses a VLP that includes influenza HA protein and plant lipids, as well as a nucleic acid encoding influenza HA and associated vectors. These VLPs can be utilized to formulate influenza vaccines or to enhance existing vaccine formulations.
Career Highlights
Sonia Trépanier is associated with Medicago Inc., a company that specializes in developing plant-based vaccines. Her work at Medicago has positioned her as a key player in the biotechnology sector, particularly in vaccine innovation.
Collaborations
Sonia collaborates with talented individuals such as Louis-Philippe Vézina and Nathalie Landry. These collaborations contribute to the advancement of her research and the development of effective vaccine solutions.
Conclusion
Sonia Trépanier's contributions to the field of influenza vaccine development through her innovative patent demonstrate her commitment to improving public health. Her work at Medicago Inc. and collaborations with other experts highlight the importance of teamwork in scientific advancements.